The Blue Box is an innovative breast cancer screening solution designed for women aged 20-49 who are looking for reliable and accessible testing options. This unique device offers a pain-free and radiation-free method to detect breast cancer in urine, boasting a sensitivity of 88.42% which outperforms traditional mammography. Developed by The Blue Box Biomedical Solutions, S.L., the tool aims to address the critical gap in breast cancer screening for younger women, who currently lack reliable testing methods. The Blue Box will launch in gynecology clinics in 2025, with clinical trials scheduled for 2024, and operates on a Diagnostics-as-a-Service subscription model.
• pain-free breast cancer screening
• diagnostics-as-a-service subscription model
• accessibility for women aged 20-49
• high sensitivity (88.42%)
• clinical trials set for 2024
• radiation-free detection
• low-cost urine-based test
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View Details